Palliative care is underutilized in nursing homes
Palliative care, specialized medical care focusing on providing relief from the symptoms — including pain — and the stress of serious illness, is underutilized in nursing homes, despite… read more.
Palliative care, specialized medical care focusing on providing relief from the symptoms — including pain — and the stress of serious illness, is underutilized in nursing homes, despite… read more.
Many pregnant people have chronic medical conditions, and although they are usually closely monitored during pregnancy, they often face barriers when transitioning to primary care following delivery. A… read more.
Gilead Sciences, Inc announced its program for the upcoming 25th International AIDS Conference (AIDS 2024), taking place in Munich, Germany, and virtually, from July 22-26. As the leading… read more.
The addition of durvalumab (Imfinzi) to gemcitabine and cisplatin demonstrated a sustained overall survival (OS) benefit vs chemotherapy alone in patients with unresectable, locally advanced or metastatic biliary… read more.
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects. While responsible for saving many lives, this treatment sometimes causes… read more.
Phathom Pharmaceuticals, Inc. announced the FDA has approved Voquezna (vonoprazan) 10 mg tablets for the relief of heartburn associated with Non-Erosive Gastroesophageal Reflux Disease (Non-Erosive GERD) in adults…. read more.
The recent surge in people seeking mental health care across the country has led to long wait times for first appointments with therapists and psychiatrists. Now, a new… read more.
Merck, known as MSD outside of the United States and Canada, announced upcoming data presentations and programming at the 25th International AIDS Conference (AIDS 2024), taking place July 22-26,… read more.
Zai Lab Limited and argenx announced that China’s National Medical Products Administration (NMPA) approved the Biologics License Application (BLA) for efgartigimod alfa injection (subcutaneous injection) (efgartigimod SC), 1,000mg… read more.
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers… read more.
Sobi announced the publication of full results from the Phase III XTEND-Kids study in The New England Journal of Medicine (NEJM) confirming the safety and efficacy profile of… read more.
Some of the UK’s most recognisable TV doctors are increasingly being “deepfaked” in videos to sell scam products across social media, finds The BMJ today. Trusted names including Hilary Jones,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.